ORAL CONTRACEPTIVES WITH ESTROGEN LEVELS ABOVE 50 MCG SHOULD BE DISCONTINUED FOR USE IN CONTRACEPTION, FDA ADVISORY COMMITTEE RECOMMENDS ON JAN. 15